FIELD VACCINATION WITH PALM OIL ADJUVANTED FEED-BASED STREPTOCOCCUS AGALACTIAE BACTERIN PROTECTS TILAPIA FROM STREPTOCOCCOSIS
Mohd Syafiq Mohammad Ridzuan1,2, Azila Abdullah2, Norazsida Ramli3, Hanan Mohd Yusof4, Mohd Firdaus-Nawi1,*
1Department of Marine Science, Kulliyyah of Science, International Islamic University Malaysia, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia
2National Fish Health Research Centre (NaFisH), Fisheries Research Institute (FRI) Batu Maung, Department of Fisheries Malaysia, 11960 Batu Maung, Penang, Malaysia
3Kulliyyah of Allied Health Science, International Islamic University Malaysia, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia
4Fisheries Research Institute (FRI) Glami Lemi, Department of Fisheries Malaysia, 71660 Titi Jelebu, Negeri Sembilan, Malaysia
*Corresponding author: firdausn@iium.edu.my
Tilapia (Oreochromis sp.) is one of the most important globally traded commodities in freshwater aquaculture industry. Intensive tilapia farming is, however, threatened by a bacterial infection caused by Streptococcus agalactiae, the causative agent of streptococcosis. Therefore, a tilapia farm that experiencing the endemic of the disease was selected to assess the efficacy of palm oil adjuvanted feed-based streptococcosis vaccine on naturally occurring streptococcosis. A total of 6,000 red tilapias were selected and divided evenly into six cages. Fish from Group 1 in cages number 1 and 2 were not vaccinated to represent negative control. Group 2 in cages number 3 and 4 were vaccinated twice on week 0 and week 2 (single booster), while Group 3 in number cages 5 and 6 were vaccinated thrice on week 0, week 2, and week 6 (double booster). Vaccination was done by oral administration of the palm oil adjuvanted feed-based bacterin vaccine at an average of 5% body weight. Organ samples of eye, brain, and kidney were collected to isolate the bacteria at two-weeks intervals until the end of the 16-week trial period. From the study, S. agalactiae was isolated as early as week 2 at an average of 11.1 ± 19.2% of the sampled fish but increased to 21.1 ± 5.1% in week 4, to 12.2 ± 21.2% in week 6, to 30.0 ± 26.5% in week 10 and 21.1 ± 10.2% in week 14. The average isolation rate was 19.6 ± 20.2%, 11.5 ± 11.3%, and 8.2 ± 9.4% of the fish sampled from unvaccinated, single, and double booster groups, respectively. At the end of the study period, the mortality rate was 23.6 ± 1.8% for unvaccinated, 14.5 ± 5.9% for single booster and 6.4 ± 0.4% for double booster groups. These results indicate that a double booster vaccination regime with palm oil adjuvanted vaccine can reduce the incidence of streptococcosis to 11.4% and improve the survival rate to 93.6%. Given current tilapia farming practices and economic constraints, oral administration may be the most suitable approach for vaccination.
Keywords: Oral vaccination, Field trial, Tilapia, Streptococcosis, Streptococcus agalactiae